MALME-3M Cells
USD$540.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The MALME-3M cell line is a human melanoma model used extensively in cancer research to investigate mechanisms of melanoma progression, immune evasion, and drug resistance. This cell line is derived from a metastatic melanoma lesion and demonstrates several characteristics relevant to aggressive melanoma, including its ability to express key oncogenic markers such as HER2 and its role in modulating the tumor microenvironment. Studies involving MALME-3M have highlighted its responsiveness to targeted therapies, such as bispecific antibodies aimed at HER2, and its use in evaluating T-cell mediated immunotherapies. One significant area of research involving MALME-3M cells is their utility in studying the mechanisms of immune evasion in melanoma. For instance, co-culture systems pairing MALME-3M with immune cells allow researchers to explore how melanoma cells modulate immune responses through pathways like PD-1/PD-L1 and other immune checkpoint inhibitors. This cell line has also been genetically modified to study the effects of gene perturbations on immune interactions, making it a valuable tool for high-throughput genetic screening. In addition to its role in immunological studies, MALME-3M cells are instrumental in exploring the effects of growth hormone (GH) on melanoma progression. Research has demonstrated that GH can enhance drug resistance and metastatic potential in MALME-3M cells by altering the composition of melanoma-derived exosomes. These exosomes can transfer drug resistance and migration-promoting factors to other cells in the tumor microenvironment. Such studies underscore the potential of targeting GH signaling pathways as a therapeutic strategy for overcoming melanoma chemoresistance. |
|---|---|
| Organism | Human |
| Tissue | Skin |
| Disease | Melanoma |
| Metastatic site | Lung |
| Synonyms | Malme-3M, MALME 3M, Malme-3 M, MALME.3M, Malme3M, MALME3M, Malme-3 Monolayer |
Characteristics
| Age | 43 years |
|---|---|
| Gender | Male |
| Ethnicity | Caucasian |
| Morphology | Fibroblast-like |
| Cell type | Fibroblast |
| Growth properties | Adherent |
Regulatory Data
| Citation | MALME-3M (Cytion catalog number 305583) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1438 |
Biomolecular Data
| Antigen expression | HLA A2, Aw30, B13, B40(+/-), DRw7 |
|---|---|
| Tumorigenic | Yes, in nude mice |
Handling
| Culture Medium | IMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3 (Cytion article number 820800a) |
|---|---|
| Supplements | Supplement the medium with 20% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with TrypLE Express, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 3 x 104 cells/cm2 |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305583-180326 | Certificate of Analysis | 13. Apr. 2026 | 305583 |